The dominant role of CPP32 subfamily in Fas-mediated hepatitis

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 4, 1998, Pages 450-454

  Suzuki, Atsushi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; HEPATITIS; LIVER INJURY; MOUSE; NONHUMAN; PROTEIN FAMILY; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALIA;

EID: 0031892041     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44256     Document Type: Article

References (36)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991.
2. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993.
3. Nagata S, Golstein P. The Fas death factor. Science 267:1449-1456, 1995.
4. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NC, Jenkins NA, Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279, 1992.
5. Suzuki A, Enari M, Eguchi Y, Matsuzawa A, Nagata S, Tsujimoto Y, Iguchi T. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J 15:211-215, 1996.
6. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809, 1993.
7. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359, 1994.
8. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204:468-474, 1994.
9. Galle PR, Hofman WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223-1230, 1995.
10. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Med 2:80-86, 1996.
11. Rodrigues I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J Exp Med 183:1031-1036, 1996.
12. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode. C. elegans. Cell 44:817-829, 1986.
13. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-652, 1993.
14. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornbery NA, Mong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996.
15. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 267:30761-30764, 1994.
16. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723-726, 1996.
17. Hasegawa J, Kamada S, Kamiike W, Shimizu S, Imazu T, Matsuda H, Tsujimoto Y. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res 56:1713-1718, 1996.
18. Boldin MP, Goncharov TM, Golstev YV, Wallach D. Involvement of MACH, a novel MORT-1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85:803-815, 1996.
19. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827, 1996.
20. Tsujimoto Y, Yunis J, Nowell PC, Croce CM. Cloning of the chromosomal breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science 226:1097-1099, 1984.
21. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988.
22. Tsujimoto Y. Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell. Oncogene 4:1331-1336, 1989.
23. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627, 1993.
24. Negrini M, Silini E, Kozak C, Tsujimoto Y, Croce CM. Molecular analysis of mbcl-2: Structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 49:455-463, 1987.
25. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, Tsujimoto Y. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13:21-29, 1996.
26. Rodriguez I, Matsuura K, Ody C, Nagata S, Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184:2067-2072, 1996.
27. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980.
28. Suzuki A, Matsuzawa A, Iguchi T. Down regulation of bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tracts. Oncogene 13:31-37, 1996.
29. Ogasawara J, Suda T, Nagata S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med 181:485-491, 1995.
30. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y. Bcl-2 expression prevents activation of ICE protease cascade. Oncogene 12:2251-2257, 1996.
31. Suzuki A, Iwasaki M, Kato M, Wagai N. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp Cell Res 233:41-47, 1997.
32. Nicholson DW, Ali A, Thornbery NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnic YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43, 1995.
33. Suzuki A, Iwasaki M, Wagai N. Involvement of cytoplasmic serine-proteinase and CPP32 subfamily in the molecular machinery of caspase 3 activation during Fas-mediated apoptosis. Exp Cell Res 233:48-55, 1997.
34. Suzuki A. Amyloid β-protein induces necrotic cell death mediated by ICE cascade in PC12 cells. Exp Cell Res 234:507-511.
35. Suzuki A, Kato M. Chemotherapeutic agent CPT-11 induces the new expression of apoptosis initiator to cytoplasm. Exp Cell Res 227:154-159, 1996.
36. Suzuki A, Matsuzawa A, Kato M. Involvement of CPP32/Yama-like protease in CPT-11-induced death signal transduction pathway. Toxicol in vitro 10:693-700, 1996.